Abstract
Globally, low back pain (LBP) is one of the most common health problems affecting humans. The lifetime prevalence of non-specific LBP is approximately 84%, with the chronic prevalence at about 23%. Chronic LBP in humans is defined as LBP that persists for more than 12 weeks without a significant pain improvement. Although there are numerous evidence-based guidelines on the management of acute LBP, this is not the case for chronic LBP, which is regarded as particularly difficult to treat. Research aimed at discovering new drug treatments for alleviation of chronic mechanical LBP is lacking due to the paucity of knowledge on the pathobiology of this condition, despite its high morbidity in the affected adult population. For a debilitating condition such as chronic LBP, it is necessary to assess the sustained effects of pharmacotherapy of various agents spanning months to years. Although many rodent models of mechanical LBP have been developed to mimic the human condition, some of the major shortcomings of many of these models are (1) the presence of a concurrent neuropathic component that develops secondary to posterior intervertebral disc puncture, (2) severe model phenotype, and/or (3) use of behavioural endpoints that have yet to be validated for pain. Hence, there is a great, unmet need for research aimed at discovering new biological targets in rodent models of chronic mechanical LBP for use in drug discovery programs as a means to potentially produce new highly effective and well-tolerated analgesic agents to improve relief of chronic LBP. On a cautionary note, it must be borne in mind that because humans and rats display orthograde and pronograde postures, respectively, the different mechanical forces on their spines add to the difficulty in translation of promising rodent data to humans.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Airaksinen O et al (2006) Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 15(Suppl 2):S192–S300. https://doi.org/10.1007/s00586-006-1072-1
Andersson GB (1998) Epidemiology of low back pain. Acta Orthopaed Scand Suppl 69:28–31
Argoff CE, Kopecky EA (2014) Patients with chronic pain and dysphagia (CPD): unmet medical needs and pharmacologic treatment options. Curr Med Res Opin 30:2543–2559. https://doi.org/10.1185/03007995.2014.967388
Atkinson JH et al (1998) A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 76:287–296. https://doi.org/10.1016/S0304-3959(98)00064-5
Atkinson JH et al (1999) Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 83:137–145
Atkinson JH et al (2007) Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. J Clin Psychopharmacol 27:135–142. https://doi.org/10.1097/jcp.0b013e3180333ed5
Balagué F, Mannion AF, Pellisé F, Cedraschi C (2012) Non-specific low back pain. Lancet 379:482–491. https://doi.org/10.1016/S0140-6736(11)60610-7
Birbara CA, Puopolo AD, Munoz DR, Sheldon EA, Mangione A, Bohidar NR, Geba GP (2003) Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—a randomized, placebo-controlled, 3-month trial. J Pain 4:307–315. https://doi.org/10.1016/S1526-5900(03)00633-3
Bogduk N (2004) Management of chronic low back pain. Med J Aust 180:79
Bogduk N (2009) On the definitions and physiology of back pain, referred pain, and radicular pain. Pain (Amsterdam) 147:17–19. https://doi.org/10.1016/j.pain.2009.08.020
Boyd LM et al (2008) Early-onset degeneration of the intervertebral disc and vertebral end plate in mice deficient in type IX collagen. Arthritis Rheum 58:164–171. https://doi.org/10.1002/art.23231
Bron JL, Helder MN, Meisel H-J, Van Royen BJ, Smit TH (2009) Repair, regenerative and supportive therapies of the annulus fibrosus: achievements and challenges. Eur Spine J 18:301–313. https://doi.org/10.1007/s00586-008-0856-x
Buynak R et al (2010) Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study. Expert Opin Pharmacother 11:1787–1804. https://doi.org/10.1517/14656566.2010.497720
Carragee EJ, Paragioudakis SJ, Khurana S (2000) Volvo Award winner in clinical studies: lumbar high-intensity zone and discography in subjects without low back problems. Spine (Phila Pa 1976 25:2987–2992
Chaparro LE, Furlan AD, Deshpande A, Mailis-Gagnon A, Atlas S, Turk DC (2013) Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev 8:04959. https://doi.org/10.1002/14651858.cd004959.pub4
Chou R (2010) Pharmacological management of low back pain. Drugs 70:387–402. https://doi.org/10.2165/11318690-000000000-00000
Chou R, Qaseem A, Snow V, Casey D, Cross JJT, Shekelle P, Owens DK (2007) Diagnosis and treatment of low back pain: a Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 147:478–491. https://doi.org/10.7326/0003-4819-147-7-200710020-00006
Chou R, Deyo R, Friedly J et al (2017) Nonpharmacologic therapies for low back pain: a systematic review for an american college of physicians clinical practice guideline. Ann Intern Med 166:493–505. https://doi.org/10.7326/M16-2459
Chou R et al (2018) The Global Spine Care Initiative: applying evidence-based guidelines on the non-invasive management of back and neck pain to low- and middle-income communities. Eur Spine J. https://doi.org/10.1007/s00586-017-5433-8
Chu LF et al (2012) Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain. Pain 153:1583–1592. https://doi.org/10.1016/j.pain.2012.02.028
Coats TL, Borenstein DG, Nangia NK, Brown MT (2004) Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial. Clin Therapeut 26:1249–1260. https://doi.org/10.1016/S0149-2918(04)80081-X
Coppes MH, Marani E, Thomeer RT, Oudega M, Groen GJ (1990) Innervation of annulus fibrosis in low back pain. Lancet 336:189–190
Coppes MH, Marani E, Thomeer RT, Groen GJ (1997) Innervation of “painful” lumbar discs. Spine (Phila Pa 1976) 22:2342–2349 (discussion 2349–2350)
Deshpande A, Furlan A, Mailis-Gagnon A, Atlas S, Turk D (2007) Opioids for chronic low-back pain. Cochrane Database Syst Rev CD004959 https://doi.org/10.1002/14651858.cd004959.pub3
Dionne CE, Dunn KM, Croft PR (2006) Does back pain prevalence really decrease with increasing age? A systematic review. Age Ageing 35:229–234. https://doi.org/10.1093/ageing/afj055
Doege KJ, Coulter SN, Meek LM, Maslen K, Wood JG (1997) A human-specific polymorphism in the coding region of the aggrecan Gene. J Biol Chem (21):13974–13979
Dworkin RH, Kirkpatrick P (2005) Pregabalin. Nat Rev Drug Discov 4:455–456. https://doi.org/10.1038/nrd1756
Enthoven WTM, Roelofs PDDM, Deyo RA, van Tulder MW, Koes BW (2016) Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012087
Eser B, Cora T, Eser O, Kalkan E, Haktanır A, Erdogan MO, Solak M (2010) Association of the polymorphisms of vitamin D receptor and aggrecan genes with degenerative disc disease. Genet Test Mol Biomarkers 14(3):313–317
Falconer MA, McGeorge M, Begg AC (1948) Observations on the cause and mechanism of symptom-production in sciatica and low-back pain. J Neurol Neurosurg Psychiatry 11:13–26. https://doi.org/10.1136/jnnp.11.1.13
Fersum KV, O’Sullivan P, Skouen JS, Smith A, Kvåle A (2013) Efficacy of classification-based cognitive functional therapy in patients with non-specific chronic low back pain: a randomized controlled trial. Eur J Pain 17:916–928. https://doi.org/10.1002/j.1532-2149.2012.00252.x
Fine PG, Mahajan G, McPherson ML (2009) Long-acting opioids and short-acting opioids: appropriate use in chronic pain management. Pain Med 10(Suppl 2):S79–S88. https://doi.org/10.1111/j.1526-4637.2009.00666.x
Foster L, Clapp L, Erickson M, Jabbari B (2001) Botulinum toxin A and chronic low back pain a randomized, double-blind study. Neurology 56:1290–1293
Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O’Brien J, Jayson MI (1997) Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet 350:178–181
Fukui D, Kawakami M, Yoshida M, Nakao S-I, Matsuoka T, Yamada H (2014) Gait abnormality due to spinal instability after lumbar facetectomy in the rat. Eur Spine J 24:2085–2094. https://doi.org/10.1007/s00586-014-3537-y
Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E (2006) Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 174:1589–1594. https://doi.org/10.1503/cmaj.051528
Genevay S, Finckh A, Mezin F, Tessitore E, Guerne P-A (2009) Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation. Arthritis Res Ther 11:R169. https://doi.org/10.1186/ar2858
Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma H-L, Flannery CR, Peluso D, Kanki K, Yang Z, Majumdar MK, Morris EA (2005) Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434(7033):644–648
Golob AL, Wipf JE (2014) Low back pain. Med Clin North Am 98:405–428. https://doi.org/10.1016/j.mcna.2014.01.003
Graham GG, Scott KF (2003) Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology 11:401–413. https://doi.org/10.1163/156856003322699573
Graumlich J (2001) Preventing gastrointestinal complications of NSAIDs Risk factors, recent advances, and latest strategies. Postgrad Med 109:117. https://doi.org/10.3810/pgm.2001.05.931
Gruber HE, Johnson T, Norton HJ, Hanley ENJ (2002) The sand rat model for disc degeneration: radiologic characterization of age-related changes: cross-sectional and prospective analyses. Spine 27:230–234
Guerin HL, Elliott DM (2007) Quantifying the contributions of structure to annulus fibrosus mechanical function using a nonlinear, anisotropic, hyperelastic model. J Orthop Res 25:508–516. https://doi.org/10.1002/jor.20324
Hale ME, Dvergsten C, Gimbel J (2005) Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 6:21–28. https://doi.org/10.1016/j.jpain.2004.09.005
Harrington JF, Messier AA, Bereiter D, Barnes B, Epstein MH (2000) Herniated lumbar disc material as a source of free glutamate available to affect pain signals through the dorsal root ganglion. Spine (Phila Pa 1976) 25:929–936
Harrington JF, Messier AA, Hoffman L, Yu E, Dykhuizen M, Barker K (2005) Physiological and behavioral evidence for focal nociception induced by epidural glutamate infusion in rats. Spine 30:606–612. https://doi.org/10.1097/01.brs.0000155422.64216.e4
Hart LG, Deyo RA, Cherkin DC (1995) Physician office visits for low back pain. Frequency, clinical evaluation, and treatment patterns from a U.S. National survey. Spine 20:11–19. https://doi.org/10.1097/00007632-199501000-00003
Heuer F, Schmidt H, Claes L, Wilke HJ (2008a) A new laser scanning technique for imaging intervertebral disc displacement and its application to modeling nucleotomy. Clin Biomech (Bristol Avon) 23:260–269. https://doi.org/10.1016/j.clinbiomech.2007.10.006
Heuer F, Schmidt H, Wilke HJ (2008b) The relation between intervertebral disc bulging and annular fiber associated strains for simple and complex loading. J Biomech 41:1086–1094. https://doi.org/10.1016/j.jbiomech.2007.11.019
Hoheisel U, Reuter R, De Freitas MF, Treede R-D (2013) Injection of nerve growth factor into a low back muscle induces long-lasting latent hypersensitivity in rat dorsal horn neurons. Pain (Amsterdam) 154:1953–1960. https://doi.org/10.1016/j.pain.2013.05.006
Hoy D, Brooks P, Blyth F, Buchbinder R (2010) The epidemiology of low back pain. Best Pract Res Clin Rheumatol 24:769–781. https://doi.org/10.1016/j.berh.2010.10.002
Hu P, Feng B, Wang G, Ning B, Jia T (2015) Microarray based analysis of gene regulation by microRNA in intervertebral disc degeneration. Mol Med Rep 12(4):4925–4930
Ilic MZ, Handley CJ, Robinson HC, Mok MT (1992) Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 294(1):115–122
Ji RR, Xu ZZ, Gao YJ (2014) Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 13(7):533–548
Johnson WEB, Caterson B, Eisenstein SM, Roberts S (2005) Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro. Spine 30:1139. https://doi.org/10.1097/01.brs.0000162624.95262.73
Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJEM, Ostelo RWJG, Guzman J, van Tulder MW (2015) Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ 350:h444. https://doi.org/10.1136/bmj.h444
Katz JN (2006) Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg 88:21–24. https://doi.org/10.2106/JBJS.E.01273
Katz J, Pennella-Vaughan J, Hetzel RD, Kanazi GE, Dworkin RH (2005) A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. J Pain 6:656–661. https://doi.org/10.1016/j.jpain.2005.05.002
Kawaguchi Y, Osada R, Kanamori M, Ishihara H, Ohmori K, Matsui H, Kimura T (1999) Association between an aggrecan gene polymorphism and lumbar disc degeneration. Spine 24:2456
Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Anderson DG (2013) The molecular basis of intervertebral disc degeneration. Spine J 13(3):318–330
Kim J-S et al (2011) The rat intervertebral disk degeneration pain model: relationships between biological and structural alterations and pain. Arthritis Res Ther 13:R165–R165. https://doi.org/10.1186/ar3485
Kobayashi Y, Sekiguchi M, Konno S-I, Kikuchi S-I (2010) Increased intramuscular pressure in lumbar paraspinal muscles and low back pain: model development and expression of substance P in the dorsal root ganglion. Spine (Philadelphia, Pa 1976) 35:1423–1428. https://doi.org/10.1097/brs.0b013e3181c645bb
Koes BW, Van Tulder M, Lin C-WC, Macedo LG, McAuley J, Maher C (2010) An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J 19:2075–2094. https://doi.org/10.1007/s00586-010-1502-y
Kopecky EA, Vaughn B, Lagasse S, O’connor M (2017) Tolerability, safety, and effectiveness of oxycodone DETERx in elderly patients ≥ 65 years of age with chronic low back pain: a randomized controlled trial. Drugs Aging 34:603–613. https://doi.org/10.1007/s40266-017-0473-7
Kumar S, Beaton K, Hughes T (2013) The effectiveness of massage therapy for the treatment of nonspecific low back pain: a systematic review of systematic reviews. Int J Gen Med 6:733–741. https://doi.org/10.2147/IJGM.S50243
Kuslich SD, Ulstrom CL, Michael CJ (1991) The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthoped Clin North Am 22:181
Lee KS, Kim J, Yoon YW, Lee MG, Hong SK, Han HC (2007) The peripheral role of group I metabotropic glutamate receptors on nociceptive behaviors in rats with knee joint inflammation. Neurosci Lett 416(2):123–127
Lee J-H, Choi T-Y, Lee MS, Lee H, Shin B-C, Lee H (2013) Acupuncture for acute low back pain: a systematic review. Clin J Pain 29:172–185
Li Z et al (2014) Both expression of cytokines and posterior annulus fibrosus rupture are essential for pain behavior changes induced by degenerative intervertebral disc: an experimental study in rats. J Orthop Res 32:262–272. https://doi.org/10.1002/jor.22494
Lidgren L (2003) The bone and joint decade 2000–2010. Bull World Health Organ 81:629
Lohmander LS, Neame PJ, Sandy JD (1993) The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum 36:1214–1222
Manchikanti L, Pampati V, Kaye AD, Hirsch JA (2018) Therapeutic lumbar facet joint nerve blocks in the treatment of chronic low back pain: cost utility analysis based on a randomized controlled trial. Korean J Pain 31(1):27–38
Ma T, Guo CJ, Zhao X, Wu L, Sun SX, Jin QH (2015) The effect of curcumin on NF-kappaB expression in rat with lumbar intervertebral disc degeneration. Eur Rev Med Pharmacol Sci 19:1305–1314
Manusov EG (2012) Evaluation and diagnosis of low back pain. Prim Care 39:471–479. https://doi.org/10.1016/j.pop.2012.06.003
Mashayekhi F, Shafiee G, Kazemi M, Dolati P (2010) Lumbar disk degeneration disease and aggrecan gene polymorphism in northern Iran. Biochem Genet 48(7–8):684–689
McCarthy PW, Carruthers B, Martin D, Petts P (1991) Immunohistochemical demonstration of sensory nerve fibers and endings in lumbar intervertebral discs of the rat. Spine (Phila Pa 1976) 16:653–655
Melrose J, Roberts S, Smith S, Menage J, Ghosh P (2002) Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration. Spine (Phila Pa 1976) 27:1278–1285
Merskey H, Bogduk N, International Association for the Study of P (1994) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms, vol Book, Whole. IASP Press, Seattle
Miyagi M et al (2011) Disk injury in rats produces persistent increases in pain-related neuropeptides in dorsal root ganglia and spinal cord glia but only transient increases in inflammatory mediators: pathomechanism of chronic diskogenic low back pain. Spine (Phila Pa 1976) 36:2260–2266. https://doi.org/10.1097/brs.0b013e31820e68c7
Miyagi M et al (2013) Assessment of pain behavior in a rat model of intervertebral disc injury using the catwalk gait analysis system. Spine 38:1459–1465. https://doi.org/10.1097/BRS.0b013e318299536a
Miyagi M, Miyagi M, Millecamps M, Danco AT, Ohtori S (2014) ISSLS prize winner: increased innervation and sensory nervous system plasticity in a mouse model of low back pain due to intervertebral disc degeneration. Spine (Phila Pa 1976) 39:1345–1354. https://doi.org/10.1097/brs.0000000000000334
Moon SM, Yoder JH, Wright AC, Smith LJ, Vresilovic EJ, Elliott DM (2013) Evaluation of intervertebral disc cartilaginous endplate structure using magnetic resonance imaging. Eur Spine J 22:1820–1828. https://doi.org/10.1007/s00586-013-2798-1
Morlion B (2011) Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Curr Med Res Opin 27:11–33. https://doi.org/10.1185/03007995.2010.534446
Murata Y, Onda A, Rydevik B, Takahashi K, Olmarker K (2004) Distribution and appearance of tumor necrosis factor-alpha in the dorsal root ganglion exposed to experimental disc herniation in rats. Spine 29:2235. https://doi.org/10.1097/01.brs.0000142223.30453.e5
Murray CJL, Lopez AD (2013) Measuring the global burden of disease. N Engl J Med 369:448–457. https://doi.org/10.1056/NEJMra1201534
Navratilova E et al (2012) Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc Natl Acad Sci USA 109:20709–20713. https://doi.org/10.1073/pnas.1214605109
Navratilova E et al (2015) Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain. J Neurosci 35:7264–7271. https://doi.org/10.1523/JNEUROSCI.3862-14.2015
Oehme D, Goldschlager T, Ghosh P, Rosenfeld JV (2015) Cell-based therapies used to treat lumbar degenerative disc disease: a systematic review of animal studies and human clinical trials. Stem Cells Int 2015:1–16. https://doi.org/10.1155/2015/946031
Ohrt-Nissen S, Døssing KB, Rossing M, Lajer C, Vikeså J, Nielsen FC, Friis-Hansen L, Dahl B (2012) Characterization of miRNA expression in human degenerative lumbar disks. Connect Tissue Res 54(3):197–203
Ohtori S et al (1999) Sensory innervation of the dorsal portion of the lumbar intervertebral disc in rats. Spine (Phila Pa 1976) 24:2295–2299
Olmarker K (2008) Puncture of a lumbar intervertebral disc induces changes in spontaneous pain behavior: an experimental study in rats. Spine (Phila Pa 1976) 33:850
Olmarker K, Storkson R, Berge OG (2002) Pathogenesis of sciatic pain: a study of spontaneous behavior in rats exposed to experimental disc herniation. Spine (Phila Pa 1976) 27:1312–1317
Olmarker K, Nutu M, Storkson R (2003) Changes in spontaneous behavior in rats exposed to experimental disc herniation are blocked by selective TNF-alpha inhibition. Spine (Phila Pa 1976) 28:1635–1641. https://doi.org/10.1097/01.brs.0000083162.35476.ff (discussion 1642)
OpenStax (2017) Anatomy & Physiology. OpenStax CNX. http://cnx.org/contents/FPtK1zmh@8.108:4CMef3D9@4/The-Vertebral-Column. Accessed 2 Aug 2017
Osgood DP, Harrington WF, Kenney EV, Harrington JF (2013) The utility of ionotropic glutamate receptor antagonists in the treatment of nociception induced by epidural glutamate infusion in rats. Surg Neurol Int 4(1):106
Ozaki S, Muro T, Ito S, Mizushima M (1999) Neovascularization of the outermost area of herniated lumbar intervertebral discs. J Orthop Sci 4:286–292
Ozawa T, Ohtori S, Inoue G, Aoki Y, Moriya H, Takahashi K (2006) The degenerated lumbar intervertebral disc is innervated primarily by peptide-containing sensory nerve fibers in humans. Spine (Phila Pa 1976) 31:2418–2422. https://doi.org/10.1097/01.brs.0000239159.74211.9c
Park CK, Xu ZZ, Liu T, Lü N, Serhan CN, Ji RR (2011) Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. J Neurosci 31(50):18433–18438
Peng B, Hou S, Wu W, Zhang C, Yang Y (2006) The pathogenesis and clinical significance of a high-intensity zone (HIZ) of lumbar intervertebral disc on MR imaging in the patient with discogenic low back pain. Eur Spine J 15:583–587. https://doi.org/10.1007/s00586-005-0892-8
Postacchini F, Bellocci M, Massobrio M (1984) Morphologic changes in annulus fibrosus during aging. An ultrastructural study in rats. Spine (Phila Pa 1976) 9:596–603
Risbud MV, Shapiro IM (2014) Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat Rev Rheumatol 10(1):44–56
Roberts S, Evans H, Trivedi J, Menage J (2006) Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 88(Suppl 2):10–14. https://doi.org/10.2106/JBJS.F.00019
Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW (2008) Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev (1):CD000396 https://doi.org/10.1002/14651858.cd000396.pub3
Romanò CL, Romanò D, Bonora C, Mineo G (2009) Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthopaed Traumatol 10:185–191. https://doi.org/10.1007/s10195-009-0077-z
Rousseau MA, Ulrich JA, Bass EC, Rodriguez AG, Liu JJ, Lotz JC (2007) Stab incision for inducing intervertebral disc degeneration in the rat. Spine (Phila Pa 1976) 32:17–24. https://doi.org/10.1097/01.brs.0000251013.07656.45
Saarto T, Wiffen PJ (2007) Antidepressants for neuropathic pain. Cochrane Database Syst Rev (4):CD005454 https://doi.org/10.1002/14651858.cd005454.pub2
Salzmann E, Pforringer W, Paal G et al (1992) Treatment of chronic low-back syndrome with tetrazepam in a placebo controlled double-blind trial. J Drug Dev 4:219–228
Saragiotto BT, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG (2016) Paracetamol for low back pain. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012230
Savigny P, Watson P, Underwood M, Guideline Development G (2009) Early management of persistent non-specific low back pain: summary of NICE guidance. BMJ 338:b1805. https://doi.org/10.1136/bmj.b1805
Sdrulla AD, Guan Y, Raja SN (2018) Spinal cord stimulation: clinical efficacy and potential mechanisms pain practice. Pain Pract. https://doi.org/10.1111/papr.12692
Searle A, Spink M, Ho A, Chuter V (2015) Exercise interventions for the treatment of chronic low back pain: a systematic review and meta-analysis of randomised controlled trials. Clin Rehab 29:1155–1167. https://doi.org/10.1177/0269215515570379
Seki S, Asanuma-Abe Y, Masuda K, Kawaguchi Y, Asanuma K, Muehleman C, Iwai A, Kimura T (2009) Effect of small interference RNA (siRNA) for ADAMTS5 on intervertebral disc degeneration in the rabbit anular needle-puncture model. Arthritis Res Ther 11(6):R166
Shi C et al (2018) Animal models for studying the etiology and treatment of low back pain. J Orthop Res. https://doi.org/10.1002/jor.23741
Shinohara H (1970) A study on lumbar disc lesion: significance of histology of free nerve endings in lumbar disc J Jpn Orthop Assoc 44:553–570
Sills GJ (2006) The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6:108–113. https://doi.org/10.1016/j.coph.2005.11.003
Sinclair SM et al (2011) Attenuation of inflammatory events in human intervertebral disc cells with a tumor necrosis factor antagonist. Spine 36:1190–1196. https://doi.org/10.1097/BRS.0b013e3181ebdb43
Skljarevski V et al (2009) A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 16:1041–1048. https://doi.org/10.1111/j.1468-1331.2009.02648.x
Smith MT, Goh WH (2011) Opioid Analgesics. In: Racz GB, Noe CE (eds) Pain management: current issues and opinions. Intech Open Access, Rijeka, Croatia, pp 287–306. https://doi.org/10.5772/29035
Smith MT, Muralidharan A (2014) Pain pharmacology and the pharmacological management of pain. In: van Griensven H, Strong J, Unruh AM (eds) Pain: a textbook for health professionals, 2nd edn. Elsevier, London, pp 159–180
Solovieva S et al. (2007) Association between the aggrecan gene variable number of tandem repeats polymorphism and intervertebral disc degeneration. Spine 32:1700. https://doi.org/10.1097/BRS.0b013e3180b9ed51
Steiner DJ, Sitar S, Wen W, Sawyerr G, Munera C, Ripa SR, Landau C (2011) Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched randomized, double-blind, placebo-controlled study. J Pain Symptom Manag 42:903–917. https://doi.org/10.1016/j.jpainsymman.2011.04.006
Tambeli CH, Young A, Levine JD, Gear RW (2003) Contribution of spinal glutamatergic mechanisms in heterosegmental antinociception induced by noxious stimulation. Pain 106:173–179
Thapa SS, Lakhey RB, Sharma P, Pokhrel RK (2016) Correlation between clinical features and magnetic resonance imaging findings in lumbar disc prolapse. J Nepal Health Res Counc 14:85–88
Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G (2006) Acetaminophen for osteoarthritis. Cochrane Database Syst Rev (1):CD004257 https://doi.org/10.1002/14651858.cd004257.pub2
Tracey I, Ploghaus A, Gati JS, Clare S, Smith S, Menon RS, Matthews PM (2002) Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 22:2748
Urquhart DM, Hoving JL, Assendelft WJJ, Roland M, van Tulder MW (2008) Antidepressants for non-specific low back pain. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD001703.pub3
Vogt BA (2005) Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci 6:533–544. https://doi.org/10.1038/nrn1704
Vorsanger GJ, Xiang J, Gana TJ, Pascual ML, Fleming RR (2008) Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manage 4:87–97
Waddel G, Burton KA, van Tulder MW, Ostelo RWJG, Koes BW (2001) Clinical guidelines for the management of low back pain in primary care: an international comparison. Spine 26:2504–2513. https://doi.org/10.1097/00007632-200111150-00022
Wager TD, Scott DJ, Zubieta J-K (2007) Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci USA U6 - ctx_ver=Z3988-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info:sid/summonserialssolutionscom&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rftgenre=article&rftatitle=Placebo+effects+on+human+mu-opioid+activity+during+pain&rftjtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&rftau=Wager%2C+Tor+D&rftau=Scott%2C+David+J&rftau=Zubieta%2C+Jon-Kar&rftdate=2007-06-26&rfteissn=1091-6490&rftvolume=104&rftissue=26&rftspage=11056&rft_id=info:pmid/17578917&rftexternalDocID=17578917¶mdict=en-US U7. J Art 104:11056
Wang J, Markova D, Anderson DG, Zheng Z, Shapiro IM, Risbud MV (2011) TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. J Biol Chem 286 (46):39738–39749
Wang C, Wang WJ, Yan YG, Xiang YX, Zhang J, Tang ZH, Jiang ZS (2015) MicroRNAs: New players in intervertebral disc degeneration. Clinica Chimica Acta 450:333–341
Wang C, Yu X, Yan Y, Yang W, Zhang S, Xiang Y, Zhang J, Wang W (2017) Tumor necrosis factor-α: a key contributor to intervertebral disc degeneration. Acta Biochim Biophys Sin 49(1):1–13
Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, Lin C-WC (2014) Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet 384:1586–1596. https://doi.org/10.1016/S0140-6736(14)60805-9
Wong JJ et al (2015) Clinical practice guidelines for the management of conditions related to traffic collisions: a systematic review by the OPTIMa Collaboration. Disabil Rehabil 37:471–489. https://doi.org/10.3109/09638288.2014.932448
Wong JJ et al (2017) Clinical practice guidelines for the noninvasive management of low back pain: a systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur J Pain 21:201–216. https://doi.org/10.1002/ejp.931
Wood KB, Garvey TA, Gundry C, Heithoff KB (1995) Magnetic resonance imaging of the thoracic spine. Evaluation of asymptomatic individuals. J Bone Joint Surg Am 77:1631–1638
Xu Z-Z et al (2010) Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16:592–597. http://www.nature.com/nm/journal/v16/n5/suppinfo/nm.2123_S1.html
Ye L, Xie W, Strong JA, Zhang J-M (2014) Blocking the mineralocorticoid receptor improves effectiveness of steroid treatment for low back pain in rats. Anesthesiology (Philadelphia) 121:632–643. https://doi.org/10.1097/ALN.0000000000000277
Zhang L, Lu Y, Chen Y, Westlund KN (2002) Group I metabotropic glutamate receptor antagonists block secondary thermal hyperalgesia in rats with knee joint inflammation. J Pharmacol Exp Ther 300:149–156
Zhang WG, Zhang LC, Peng ZD, Zeng YM (2009) Intrathecal injection of GluR6 antisense oligodeoxynucleotides alleviates acute inflammatory pain of rectum in rats. Neurosci Bull 25:319–323. https://doi.org/10.1007/s12264-009-0326-4
Zhao B, Yu Q, Li H, Guo X, He X (2014) Characterization of microRNA expression profiles in patients with intervertebral disc degeneration. Int J Mol Med 33:43–50
Zubieta JK, Stohler CS (2009) Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci 1156:198–210. https://doi.org/10.1111/j.1749-6632.2009.04424.x
Acknowledgements
TP is supported by the Research Training Program to undertake a Ph.D. at the Centre for Integrated Preclinical Drug Development (CIPDD) at The University of Queensland. The authors acknowledge the Queensland Government Smart State Research Programme for supporting CIPDD research infrastructure. CIPDD is also supported by Therapeutic Innovation Australia (TIA). TIA is supported by the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS) program.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, T.S.W., Kuo, A. & Smith, M.T. Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data. Inflammopharmacol 26, 881–898 (2018). https://doi.org/10.1007/s10787-018-0493-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-018-0493-x